Delivers computational platforms and therapeutics to selectively eliminate pathogenic immune cells in vivo.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ai3Bio provides a biotechnology platform designed to target and eliminate disease-causing inflammatory T cells at their root to treat autoimmune conditions. The company utilizes artificial intelligence and computational analysis of diseased tissue to identify shared cellular markers across autoimmune diseases and engineer therapeutics that remove rogue immune cells.
ai3Bio Funding
Sign up to gain insights into ai3Bio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A | Sep 29, 2026 | 24M | ||
| Series A-4 | Sep 29, 2026 | 23M | ||
| Series A-1 | Dec 29, 2023 | 15M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
ai3Bio Management Team
Investors
Cockrell Interests
Tanis Ventures
UPMC Enterprises
Ziff Capital Partners
ai3Bio Valuations & Financials
View real-time NPM data on ai3Bio stock including daily ai3Bio stock price estimates, valuation history, and historical share price information. Access ai3Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ai3Bio pricing across six independent market signals. Looking for private company due diligence data sources on ai3Bio? Get in touch to learn more.
Similar Companies
like ai3Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
XGS Energy
Climate & Sustainability
Produces geothermal energy through water-independent, modular heat extraction systems.
Shop LIT Live
Media & Entertainment
Offers interactive broadcasting technology which enables retail brands to sell products directly through real-time video streams.
Woolpert
Enterprise Software
Blends architecture, engineering, geospatial mapping, and strategic consulting into unified data-driven infrastructure solutions.
Craftt
FinTech
Provides onchain credit infrastructure connecting lenders, borrowers, and capital for efficient, transparent, and under-collateralized private credit.
Supra
Web3 & Digital Assets
Layer 1 blockchain platform offering native oracle services, verifiable randomness, automation, and cross-chain communication.
CurbStand
Mobility & Transportation
Delivers smart smartphone applications to streamline valet services and real-time parking coordination.
Physical Intelligence
AI & Machine Learning
Develops general-purpose AI systems designed to operate in the physical world, focusing on robotics and embodied intelligence.
FullCryo
Industrials
Manufactures industrial cryogenic equipment and systems, specializing in refrigeration, liquefaction, and gas separation technologies.
FAQ
We have answers
ai3Bio stock does not trade on public stock exchanges. ai3Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ai3Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ai3Bio Stock does not trade on public stock exchanges. In order to sell ai3Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ai3Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ai3Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for ai3Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ai3Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ai3Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ai3Bio is a private company and has not had an IPO. There is currently no ai3Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ai3Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
